Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

CTNMCTNM
5 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in CONTINEUM THERAPEUTICS INC

Yes. Janus Henderson holds 2,734,836 shares of CTNM (Contineum Therapeutics), worth $35.6M, as of its Q1 2026 13F filing. It increased the position by 285,857 shares (+11.7%) from Q4 2025. Janus Henderson has held CTNM since Q4 2025, across 2 quarterly 13F filings.

Current Value

$35.6M

Current Shares

2.7M

Total Value Change

+$34.6M

Total Shares Change

+2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.7M
+11.7%
$35.6M0.0%$14.10
32
2025-Q4
New
2.4M
-
$27.9M0.0%$11.40
40
2025-Q2
Exited
0
-100.0%
$00.0%$4.11
0
2025-Q1
Decreased
42,499
-37.8%
$300,4680.0%$7.07
0
2024-Q4
New
68,320
-
$1M0.0%$14.47
35

Other major holders of CTNM: Jupiter Topco LLC, BlackRock, Inc., FRANKLIN TEMPLETON INC, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used